Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials-Reference-Cited by-同舟云学术

Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials

Published:2021-04-02 Issue:5 Volume:62 Page:1130-1140
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Privitera Michael¹^ORCID,Bhathal Hari²,Wong Matthew³,Cross J. Helen⁴^ORCID,Wirrell Elaine⁵^ORCID,Marsh Eric D.⁶^ORCID,Mazurkiewicz‐Beldzinska Maria⁷^ORCID,Villanueva Vicente⁸^ORCID,Checketts Daniel⁹,Knappertz Volker¹⁰,VanLandingham Kevan¹⁰

Affiliation:

1. University of Cincinnati Medical Center Cincinnati OH USA

2. Neurocenter Barcelona Teknon Medical Center Barcelona Spain

3. Wake Forest Baptist Medical Center Winston‐Salem NC USA

4. University College London National Institute for Health Research Biomedical Research Center Great Ormond Street Institute of Child Health London UK

5. Mayo Clinic Rochester MN USA

6. Children's Hospital of Philadelphia Philadelphia PA USA

7. Medical University of Gdańsk Gdańsk Poland

8. University and Polytechnic Hospital La Fe Valencia Spain

9. GW Research Ltd. Cambridge UK

10. Greenwich Biosciences, Inc. Carlsbad CA USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.16878